FDA采用富集策略的临床试验支持药物和生物制品的审批

2019-09-04 美国食品和药品监督管理局 FDA

Docket Number:

中文标题:

FDA采用富集策略的临床试验支持药物和生物制品的审批

英文标题:

Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products Guidance for Industry

发布日期:

2019-09-04

简要介绍:

Docket Number:
FDA-2012-D-1145
Issued by:
Center for Drug Evaluation and Research
Center for Biologics Evaluation and Research

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled “Enrichment Strategies for Clinical Trials to Support Demonstration of Effectiveness of Human Drugs and Biological Products.” The purpose of this guidance is to assist industry in developing enrichment strategies that can be used in clinical investigations intended to demonstrate effectiveness (and in some cases safety) of human drugs and biological products. This guidance defines several types of enrichment strategies, provides examples of potential clinical trial designs, and discusses potential regulatory considerations when using enrichment strategies in clinical trials. This guidance finalizes the draft guidance entitled “Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products” issued on December 17, 2012.

下载附件:

(需要扣积分20分)

版权声明:
本网站所有注明来源:“梅斯医学”或“MedSci”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,否则将追究法律责任。取得书面授权转载时,须注明“来源:梅斯医学”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言

评论区 (0)
#插入话题

相关指南

FDA新冠肺炎公共卫生事件期间药物临床试验执行指南

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2020-09-09

FDA临床试验多终点设计指南(草案)

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2018-09-03

药物临床试验数据监查委员会指导原则(试行)

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2020-09-23

药物临床试验富集策略与设计指导原则(征求意见稿)

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2020-08-28

FDA扩展队列指南:首次人体试验中应用以加快肿瘤药物和生物制剂开发(草案)

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2018-08-08

药物临床试验数据递交指导原则(试行)

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2020-07-20